The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0–G1 and the G2–M Phases
Sébastien P. Tabruyn(TransCure BioServices (France)), Ingrid Struman(University of Liège)
Cited by 52
Related Papers
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
|Journal of Clinical Investigation|2013|492
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
|Basic Research in Cardiology|2013|351
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
|PLoS ONE|2011|251
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
|Nature Medicine|2014|105
hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells
|Cellular and Molecular Life Sciences|2020|56